🇺🇸 UTHR — United Therapeutics Corporation
Salud CompraPrecio actual
601,32 USD
Máx. histórico
601,32
0 días
Split 2:1 del 23/09/2009
Caída desde máximo
En máximo
Rango 52 semanas
430,02 – 609,99
Variación hoy
+0,87%
Cierre anterior
596,13
Rango de hoy
596,14 – 606,16
Volumen hoy
595.233
Peor caída histórica
-93,18%
12/07/2000 → 10/12/2001
Recuperado en 3311 días
Volatilidad anualizada ⓘ
46,95%
- Nombre completo
- United Therapeutics Corporation
- Divisa
- USD
- Mercado
- NasdaqGS
- Sector
- Salud
- Industria
- Drug Manufacturers - Specialty & Generic
- Empleados
- 1.400
- PER ⓘ
- 21,54 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 670,93 USD (puede no estar actualizado)
- Primera cotización
- 17/06/1999
- Precio actualizado
- hace 21 horas
United Therapeutics Corporation engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. It offers Tyvaso DPI, an inhaled dry powder via pre-filled and single-use cartridges; Nebulized Tyvaso, an inhaled solution via ultrasonic nebulizer; Remodulin (treprostinil) injection to treat patients with pulmonary arterial hypertension to diminish symptoms associated with exercise; Orenitram, a tablet dosage form of treprostinil, to delay disease progression and improve exercise capacity in PAH patients; and Adcirca, an oral PDE-5 inhibitor to enhance the exercise ability in PAH patients. It also markets and sells Unituxin (dinutuximab) injection, a monoclonal antibody for high-risk neuroblastoma; and Remunity Pump, which contains a pump and separate controller for Remodulin. In addition, it is involved in developing RemunityPRO Pump and Ralinepag for the treatment of PAH;and Nebulized Tyvaso, for the treatment of idiopathic pulmonary fibrosis, as well as xenografts, which are development-stage organ products. Further, it provides preclinical products, including EVLP/CLES, for lung transplant; UKidney, UHeart, UThymoKidney, a development-stage gene-edited porcine kidneys and hearts for xenotransplantation; ULobe, for allogeneic regenerative medicine; ULung, for autologous regenerative medicine; IVIVA Kidney, for autologous regenerative medicine; miroliver, for allogeneic regenerative medicine; and mirokidney, for allogeneic regenerative medicine. It has licensing and collaboration agreements with DEKA Research & Development Corp. to develop a semi-disposable system for the subcutaneous delivery of treprostinil; MannKind Corporation to develop and license treprostinil inhalation powder and the Dreamboat device; and Arena Pharmaceuticals, Inc. to develop Ralinepag. The company was founded in 1996 and is headquartered in Silver Spring, Maryland.
| Fecha | Ratio |
|---|---|
| 23/09/2009 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 20/06/2003 | 10,61 | 10,76 | 10,59 | 10,66 | +0,19% | 1,65% | 487.800 |
| 19/06/2003 | 11,36 | 11,45 | 10,43 | 10,64 | -7,24% | 8,98% | 715.600 |
| 18/06/2003 | 11,74 | 11,75 | 11,33 | 11,47 | -1,33% | 3,62% | 760.200 |
| 17/06/2003 | 11,35 | 11,75 | 11,25 | 11,62 | +2,51% | 4,41% | 839.200 |
| 16/06/2003 | 10,90 | 11,35 | 10,90 | 11,34 | +3,71% | 4,13% | 315.000 |
| 13/06/2003 | 11,23 | 11,23 | 10,89 | 10,93 | -1,97% | 2,98% | 233.600 |
| 12/06/2003 | 10,77 | 11,20 | 10,77 | 11,15 | +3,00% | 4,04% | 321.400 |
| 11/06/2003 | 10,38 | 10,83 | 10,38 | 10,83 | +2,12% | 4,34% | 597.000 |
| 10/06/2003 | 11,04 | 11,04 | 10,44 | 10,60 | +0,95% | 5,43% | 232.400 |
| 09/06/2003 | 10,65 | 10,89 | 10,46 | 10,50 | -2,10% | 4,04% | 402.000 |
| 06/06/2003 | 11,02 | 11,63 | 10,60 | 10,73 | -1,15% | 9,35% | 975.400 |
| 05/06/2003 | 10,43 | 10,94 | 10,41 | 10,85 | +3,98% | 5,13% | 454.400 |
| 04/06/2003 | 10,20 | 10,51 | 10,16 | 10,44 | +1,36% | 3,43% | 326.800 |
| 03/06/2003 | 10,20 | 10,53 | 10,20 | 10,30 | +0,64% | 3,24% | 353.400 |
| 02/06/2003 | 10,00 | 10,43 | 9,94 | 10,23 | +2,30% | 4,95% | 636.000 |
| 30/05/2003 | 9,90 | 10,06 | 9,88 | 10,00 | +1,27% | 1,87% | 174.000 |
| 29/05/2003 | 9,99 | 10,04 | 9,80 | 9,88 | -1,05% | 2,35% | 396.400 |
| 28/05/2003 | 10,22 | 10,28 | 9,86 | 9,98 | -2,06% | 4,06% | 359.400 |
| 27/05/2003 | 9,85 | 10,29 | 9,77 | 10,19 | +4,62% | 5,23% | 665.600 |
| 23/05/2003 | 9,43 | 9,79 | 9,38 | 9,74 | +2,91% | 4,40% | 723.000 |
| 22/05/2003 | 9,18 | 9,58 | 9,13 | 9,47 | +2,66% | 4,90% | 735.400 |
| 21/05/2003 | 9,16 | 9,50 | 9,10 | 9,22 | -0,05% | 4,37% | 633.600 |
| 20/05/2003 | 9,26 | 9,41 | 9,11 | 9,23 | -0,54% | 3,19% | 366.000 |
| 19/05/2003 | 9,39 | 9,48 | 9,28 | 9,28 | -0,43% | 2,18% | 374.200 |
| 16/05/2003 | 9,37 | 9,50 | 9,32 | 9,32 | -1,64% | 1,97% | 282.800 |
| 15/05/2003 | 9,48 | 9,49 | 9,38 | 9,47 | +0,42% | 1,11% | 474.400 |
| 14/05/2003 | 9,27 | 9,45 | 9,21 | 9,43 | +2,22% | 2,59% | 408.800 |
| 13/05/2003 | 9,25 | 9,52 | 9,12 | 9,23 | +0,33% | 4,38% | 898.000 |
| 12/05/2003 | 8,93 | 9,24 | 8,85 | 9,20 | +2,97% | 4,43% | 655.200 |
| 09/05/2003 | 8,84 | 8,97 | 8,65 | 8,93 | +1,48% | 3,62% | 584.600 |